Clinical Trials Logo

Filter by:
NCT ID: NCT04680871 Withdrawn - Clinical trials for Biometrics Measurement

Validation of In-Ear Sensor

Start date: January 4, 2022
Phase:
Study type: Observational

The purpose of this study is to clinically validate noninvasive in-ear sensor.

NCT ID: NCT04680416 Withdrawn - Clinical trials for Renal Clear Cell Carcinoma

Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors

Start date: December 17, 2020
Phase:
Study type: Observational

T Cell Receptor-engineered T-cell therapy (TCR T-cell therapy) offers a potentially transformative approach to treating cancer, but is currently limited by the lack of known targets (Maus and June, 2016; Ping et al., 2018). Arguably the most clinically meaningful way to discover new targets and TCRs for TCR T-cell therapy is to study the tumorinfiltrating lymphocytes of patients that are actively responding to immune checkpoint inhibitor (ICI) therapy. These T cells are clonally expanded as a result of checkpoint inhibition and are responsible for the patient's clinical response. The goal of this study is to acquire tumor and blood samples from up to 40 patients with renal cell carcinoma (RCC) malignancies who respond to ICI therapy. T cells will be isolated from these samples and the targets of their TCRs determined using TScan's genome-wide, high-throughput target ID technology. The expected outcome of this study is the discovery of a collection of new targets for TCR T-cell therapy, along with associated TCRs that will then be developed as novel therapies for patients with similar malignancies.

NCT ID: NCT04679233 Withdrawn - Radiotherapy Clinical Trials

Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients

Start date: February 2021
Phase: N/A
Study type: Interventional

Treated head and neck cancer patients are subject to tissue swelling and scarring, known as lymphedema and fibrosis (LEF). LEF in the head and neck cancer patient occurs in up to 90% of treated patients and is associated with inflammation cells. Aerobic exercise is known to mediate these same inflammatory cells in an anti-inflammatory manner due to chronic adaptation of the cells. The investigators are therefore proposing a prescription exercise study for head and neck cancer patients. This study's primary aim is feasibility and safety of the aerobic exercise prescription. Feasibility of gathering study participant inflammation markers, visible LEF, and patient LEF symptoms will be a secondary aim of the study. Patient will be asked to journal their experience for a qualitative analysis. The prescription aerobic exercise is that of high intensity interval exercise, since this form of exercise can achieve similar or better results to moderate exercise with less time and patient burden. Each exercise session will take place on a cycle ergometer, will be 5 minutes warm up, 5 minutes cool down, and 20 minutes of exercise (1 minute intervals alternated by 1 minute rests x 10 each).

NCT ID: NCT04678128 Withdrawn - Anxiety Clinical Trials

Dance4Healing: Explore the Benefits of Tele-Dance in Individuals With an Implantable Cardioverter-defibrillator (ICD)

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

This study is to determine if it is feasible to using a Telehealth Dance Platform with patients that have an implantable Cardioverter Defibrillator, and will compare the activity engagement, anxiety, and Quality of Life

NCT ID: NCT04676126 Withdrawn - Glaucoma Clinical Trials

Augmented Macular Pigment-containing Nutraceutical and Central Visual Function

Start date: May 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to prospectively analyze changes in macular pigment optical density and dermal carotenoid levels as they relate to visual field function in patients prescribed a macular pigment-containing medical food (Lumega-Z), in combination with a topical carbonic anhydrase inhibitor.

NCT ID: NCT04675086 Withdrawn - Covid19 Clinical Trials

Aralast NP With Antiviral Treatment and Standard of Care Versus Antiviral Treatment With Standard of Care in Hospitalized Patients With Pneumonia and COVID-19 Infection

Start date: January 2021
Phase: Phase 3
Study type: Interventional

This is a Randomized, Open-Label Study of the Efficacy and Safety of Aralast NP Infusion Therapy with Antiviral Treatment and standard of care versus Antiviral Treatment and standard of care (control group) in Hospitalized Patients with Pneumonia and COVID-19 Infection.

NCT ID: NCT04674410 Withdrawn - Covid19 Clinical Trials

Utility of Empiric Antibiotics for Non-intubated Novel Coronavirus Diseases 2019 Patients

Start date: March 1, 2020
Phase:
Study type: Observational

This retrospective analysis of inpatient data obtained from administrative and electronic medical records will investigate the role of empiric antibiotics on admission on the mortality for non-intubated patients presenting with Novel Coronavirus Diseases 2019 (COVID-19) associated pneumonia without extra-pulmonary sources of infection or septic shock.

NCT ID: NCT04674098 Withdrawn - Clinical trials for Hospital Acquired Condition

The Effect of Real Time Analytics on Adverse Events Among Hospitalized Patients

Start date: April 1, 2021
Phase:
Study type: Observational

This study will examine the effect of providing nurses with continuous, remote, real-time monitoring of their patient's vital signs and MEWS scores using the BAS on the occurrence of adverse events, admissions to the ICU, hospital length of stay and activation of the rapid response team among patients on non-intensive care hospital units. A longitudinal study will measure the outcome variables among an estimated 60 patients per month during 6 month intervals when the BAS is not and is available to the nursing staff.

NCT ID: NCT04673435 Withdrawn - Full Thickness Burn Clinical Trials

Permeaderm Versus Homograft for Full-thickness Burns

Start date: January 31, 2018
Phase: N/A
Study type: Interventional

Frozen Human Cadaver Allograft (FHCA) is, nowadays, the gold standard for temporary coverage of excised full-thickness burns, but is also very expensive and requires additional personnel and major storage spaces in comparison to other products. The purpose of this study is to determine the extent to which PermeaDerm® dressing promotes wound bed maturation when used as a temporary dressing for excised full-thickness burn wounds. Efficacy and safety in promoting wound bed maturation for successive autografting will be determined through direct comparison to FHCA.

NCT ID: NCT04671836 Withdrawn - Neuroimaging Clinical Trials

Lorazepam Effects on Neuroimaging Measures

Start date: January 2022
Phase: Early Phase 1
Study type: Interventional

This within-subject, double blind, randomized controlled study will investigate the effects of a widely used benzodiazepine (BZD), lorazepam, on various neuroimaging measures. The investigators will be assessing the relationship of lorazepam to resting state functional connectivity and other neuroimaging measures. Specifically, the investigators will be using a pre-identified metric, the striatal connectivity index (SCI), (Sarpal et al. 2015, 2016), a prognostic biomarker of treatment response assessing the connectivity between regions of the striatum and the cortex. The investigators hypothesize that lorazepam administration will be associated with greater SCI values compared with placebo administration; consistent with previous work suggesting short-acting benzodiazepines increase functional connectivity across brain networks.